Findings

What do systematic reviews say?

4 questions · 4 findings · 2 reviews · Headline outcomes only

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 4 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Mortality at maximal · participants with alcoholic hepatitis (all severity)

It is very uncertain whether colchicine changes mortality at maximal compared with no intervention (very low certainty).

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
OR 1.31 [0.47, 3.64]
2 studies · 139 participants
Very low

Mortality at maximal · alcohol‐related disorders (others)

It is very uncertain whether colchicine changes mortality at maximal compared with no intervention (very low certainty).

1 finding from 1 review

Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease) 2017 · Cochrane Headline outcomes only
OR 1.11 [0.8, 1.53]
2 studies · 604 participants
Very low

Mortality at maximal · people with primary biliary cholangitis

It is very uncertain whether colchicine changes mortality at maximal compared with no intervention (very low certainty).

1 finding from 1 review

Pharmacological interventions for primary biliary cholangitis 2017 · Cochrane Headline outcomes only
OR 0.77 [0.32, 1.85]
2 studies · 122 participants
Very low

Mortality at maximal · people with primary biliary cholangitis

It is very uncertain whether colchicine plus ursodeoxycholic acid (UDCA) changes mortality at maximal compared with UDCA (very low certainty).

1 finding from 1 review

Pharmacological interventions for primary biliary cholangitis 2017 · Cochrane Headline outcomes only
OR 1.84 [0.38, 8.91]
2 studies · 158 participants
Very low